Pharming Group to report second quarter and first half 2024 financial results on August 1
18 Luglio 2024 - 8:00AM
Leiden, the Netherlands, July 18,
2024: Pharming Group N.V. (“Pharming”) (Euronext
Amsterdam: PHARM/Nasdaq: PHAR) confirms it will report its
preliminary (unaudited) second quarter and first half 2024
financial results, for the period ended June 30, on Thursday,
August 1, 2024.Pharming will host a presentation for analysts and
investors at 13:30 CEST/07:30 am EDT on August 1, 2024.
To participate in the conference call, please
register in advance using the link below. Once registered, dial-in
information and a unique PIN will be provided, allowing access to
the call.
Conference call
registration:
Please note, the Company will only take
questions from dial-in attendees.
https://register.vevent.com/register/BI92328f52b76d43d394cacc1c2ba94ac4
To watch the live webcast, please register in
advance using the link below.
Webcast registration:
https://edge.media-server.com/mmc/p/awvi6h6a/
About Pharming Group N.V.
Pharming Group N.V. (EURONEXT Amsterdam:
PHARM/Nasdaq: PHAR) is a global biopharmaceutical company dedicated
to transforming the lives of patients with rare, debilitating, and
life-threatening diseases. Pharming is commercializing and
developing an innovative portfolio of protein replacement therapies
and precision medicines, including small molecules and biologics.
Pharming is headquartered in Leiden, the Netherlands, and has
employees around the globe who serve patients in over 30 markets in
North America, Europe, the Middle East, Africa, and
Asia-Pacific.
For more information, visit www.pharming.com and
find us on LinkedIn.
For further public information,
contact:
Pharming Group, Leiden, the
NetherlandsMichael Levitan, VP Investor Relations &
Corporate CommunicationsT: +1 (908) 705 1696E:
investor@pharming.com
FTI Consulting, London, UKVictoria
Foster Mitchell/Alex Shaw/Amy ByrneT: +44 203 727 1000
LifeSpring Life Sciences Communication,
Amsterdam, The NetherlandsLeon MelensT: +31 6 53 81 64
27E: pharming@lifespring.nl
- Pharming Group to report 2Q24_1H24 results_EN_18JULY24
Grafico Azioni Pharming Group NV (EU:PHARM)
Storico
Da Dic 2024 a Gen 2025
Grafico Azioni Pharming Group NV (EU:PHARM)
Storico
Da Gen 2024 a Gen 2025
